All News

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Exclusions from Medicaid eligibility based on immigration status may be linked with increased health care disparities among immigrant women compared with US-born women, a study suggested.

Pear Therapeutics announced positive real-world data for reSET, a prescription digital therapeutic (PDT) for substance use disorder.

Better understanding of risk factors in patients with chronic obstructive pulmonary disease (COPD) and adverse childhood experiences (ACEs) may lead to better management in care.

This investigation compared the histologic features of basal cell carcinoma (BCC) between organ transplant recipients and the general population.

A recent study found that Americans die younger in states with conservative policies; most patients admitted to the hospital with monkeypox also have HIV; 4 million children are uninsured due to state policies, according to new research.

The results of a study showing improved functional vision and retinal sensitivity have implications for gene therapy in ophthalmological conditions, explained Michel Michaelides, MD, FACP, a consultant ophthalmologist and a professor of ophthalmology at the University College London Institute of Ophthalmology's Genetics Department.

The findings follow recent data suggesting that esophageal dysmotility may be associated with eosinophilic esophagitis (EoE), which often presents with dysphagia.

Neil Goldfarb, president and CEO of Greater Philadelphia Business Coalition on Health (GPBCH), discussed his initial motivations for launching a business coalition 10 years ago in the Greater Philadelphia region and what accomplishments GPBCH has had so far in driving health care value.

A recently published report describes the diagnosis and treatment of a case of iron-deficiency anemia–associated thrombocytopenia secondary to recurrent nosebleeds.

Immune checkpoint inhibitors, either alone or in combination with chemotherapy, were associated with better outcomes in non–oncogene-addicted non–small cell lung cancer (NSCLC).

In an interview, the section chief of hepatology at Rush University Medical Center discussed why the addition of the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) diagnosis code K76.82 is necessary.

The limited data on heart failure (HF)-related mortality among young adults, those aged 15 to 44 years, prompted this analysis of data from 1999 to 2019 that considered HF as a contributing or underlying cause of death.

The study, say researchers, adds insight into risk factors predictive of response to dietary intervention for eosinophilic esophagitis (EoE), as dietary failure occurs in up to 30% of patients.

The FDA’s approval of teclistamab for relapsed/refractory (R/R) multiple myeloma makes it the first bispecific T-cell engager antibody to enter the treatment landscape.

Jason Ezra Hawkes, MD, MS, FAAD, board-certified dermatologist and associate professor of dermatology at the University of California Davis in Sacramento, discussed how prior authorizations and other insurance requirements are limiting treatment access in atopic dermatitis and how dermatologists can help ameliorate these approval issues.

Black and Latino Americans saw surges in health care insurance enrollment through the Affordable Care Act (ACA) between 2020 and 2022; Medicaid enrollment and spending is expected to slow in 2023; the Biden administration is preparing a national hepatitis C treatment plan.

Athena Gierbolini, president of Hope for HS, a nonprofit advocacy group for those affected with hidradenitis suppurativa (HS), spoke on common stigmas regarding HS and how clinicians can improve consultation through a culturally sensitive approach.

Microbiota restoration may be a solution for effectively treating patients with Clostridiodes difficile infection, according to researchers.

Pharmacists must take time to understand why patients are not adherent to HIV pre-exposure prophylaxis (PrEP) and what barriers exist, said Kevin N. Astle, PharmD, BCPS, BCACP, AAHIVP, CDES, assistant professor at the University of South Florida Taneja College of Pharmacy.

Dupilumab exhibited similarly significant and sustained improvements in atopic dermatitis (AD) signs, symptoms, and quality of life of adult patients with moderate to severe AD, regardless of age of disease onset, compared with placebo.

A study found that including sleep health as part of a cardiovascular health assessment improved the ability to predict cardiovascular disease (CVD).

The study sought to examine the safety and tolerability of gefapixant in Japanese patients with refractory or unexplained chronic cough.

A systematic review found that changes in neural mechanisms as a result of ketamine treatment could play a role in treatment outcomes of ketamine-assisted psychotherapy.

These new study data are based on 20 years of follow-up in 92 Chinese children with lupus nephritis.

CVS Health and a digital diagnostic startup will produce at-home tests for vitamin D, Lyme disease, sexually transmitted infections, and thyroid function; researchers identified 42 genetic variants associated with dyslexia; FDA plans updated mammogram regulations to help women with dense breasts.

The study found that in most cases, progression to treatment-resistant depression occurred within the first year.

Highlighting their ability to quickly destroy malignant cells without antigen specificity, natural killer (NK) cells have been identified as an opportunity for use, particularly in cases where T cells are not effective.

Improved outcomes associated with fidaxomicin compared with vancomycin suggest benefits from its greater use in Medicare patients, although uptake remains low despite its recommended use.

A study of women and girls from families with hemophilia in Thailand assessed the emotional impact of a carrier diagnosis and emphasized the value of comprehensive management.